Acquisition of HIV type 1 resistance by beta-chemokine-producing CD4+ T cells

AIDS Res Hum Retroviruses. 1999 Nov 1;15(16):1453-60. doi: 10.1089/088922299309964.

Abstract

The CD4+ T cell is a major target cell type for human immunodeficiency virus type 1 (HIV-1) infection. In this study, we provide evidence that the susceptibility to HIV-1 infection is variable in individual CD4+ T cells. Five CD4+ T cell clones were isolated from an HIV-1-seronegative donor and were investigated for their susceptibility to HIV-1 infection. Four CD4+ T cell clones were resistant to infection by a macrophage-tropic (R5) HIV-1 isolate whereas one clone was fully permissive. The level of susceptibility to HIV-1 correlated inversely with beta-chemokine production, including RANTES (regulated on activation, normally T cell expressed and secreted), macrophage inflammatory protein 1alpha (MIP-1alpha), and MIP-1beta. Resistance to HIV-1 infection was abrogated by the combined use of neutralizing antibodies against these three beta-chemokines. Interestingly, a complete inhibition of HIV-1 infection was observed in peripheral blood mononuclear cells on infection induced by adding the culture supernatant or a small number of HIV-1-resistant cell clones. Our results suggest the presence of a clonal self-defense mechanism within the CD4+ T cell population in vivo that involves the secretion of beta-chemokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Chemokines, CC / biosynthesis*
  • Clone Cells
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1 / immunology
  • HIV-1 / pathogenicity*
  • Humans
  • Neutralization Tests

Substances

  • Chemokines, CC